002432.SZ
九安医疗
SZSE · Healthcare · C 制造业 · CN
CNY 67.27
−4.85%Year over year
Reported trailing growth
- Revenue
- -50.4%
- EBITDA
- —
- EBIT
- +27.1%
- EPS
- +36.3%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -62.7%
- EBITDA
- -48.0%
- EBIT
- -48.3%
- Net income
- -47.9%
- EPS
- -47.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026